Gene · 580
Papers4,139
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 4,139
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prime Editing: Mechanistic Insights and DNA Repair Modulation. | Cells | 2025 | 39996750 | PubTator, text mining | PubMed |
| Considerations for hereditary breast and ovarian cancer syndrome molecular diagnosis: experience from the clinical practice. | Breast Cancer Res Treat | 2025 | 39992612 | PubTator, text mining | PubMed |
| The mutational landscape and its longitudinal dynamics in relapsed and refractory classic Hodgkin lymphoma. | Ann Hematol | 2025 | 39992429 | PubTator, text mining | PubMed |
| Genome sequencing enhances the diagnostic yield and expands the genetic landscape of male breast cancer. | Genet Med Open | 2025 | 39981113 | PubTator, text mining | PubMed |
| Mutations in homologous recombination repair genes in patients with metastatic endometrial cancer: association with clinical characteristics and prognosis. | J Gynecol Oncol | 2025 | 39950607 | PubTator, text mining | PubMed |
| Aberrant accumulation of phosphorylated BRCA1 in brainstem-type and cortical-type Lewy bodies in Lewy body disease. | J Neuropathol Exp Neurol | 2025 | 39907307 | PubTator, text mining | PubMed |
| RIOK1: A Novel Oncogenic Driver in Hepatocellular Carcinoma. | Cancer Med | 2025 | 39865406 | PubTator, text mining | PubMed |
| Primary mucinous cystadenocarcinoma of the breast: A case report and literature review. | Oncol Lett | 2025 | 39611063 | PubTator, text mining | PubMed |
| Association between homologous recombination deficiency and time to treatment failure to platinum-based chemotherapy for pancreatic cancer by using the C-CAT database. | J Gastroenterol | 2025 | 39570378 | PubTator, text mining | PubMed |
| Pathogenic Variants in Cancer Susceptibility Genes Predispose to Ductal Carcinoma In Situ of the Breast. | Clin Cancer Res | 2025 | 39513960 | PubTator, text mining | PubMed |
| Germline variants of homology-directed repair or mismatch repair genes in cervical cancer. | Int J Cancer | 2025 | 39440754 | PubTator, text mining | PubMed |
| Comparative sequencing study of mismatch repair and homology-directed repair genes in endometrial cancer and breast cancer patients from Kazakhstan. | Int J Cancer | 2025 | 39400928 | PubTator, text mining | PubMed |
| Functional Analysis of BARD1 Missense Variants on Homology-Directed Repair in Ovarian and Breast Cancers. | Mol Carcinog | 2025 | 39387837 | PubTator, text mining | PubMed |
| A portrait of germline pathogenic variants in high and moderate penetrance breast cancer genes in Brazil. | Front Oncol | 2024 | 39741970 | PubTator, text mining | PubMed |
| A Rare Case of a Malignant Proliferating Trichilemmal Tumor: A Molecular Study Harboring Potential Therapeutic Significance and a Review of Literature. | Dermatopathology (Basel) | 2024 | 39727620 | PubTator, text mining | PubMed |
| Informeasure: an R/bioconductor package for quantifying nonlinear dependence between variables in biological networks from an information theory perspective. | BMC Bioinformatics | 2024 | 39695935 | PubTator, text mining | PubMed |
| High- and Moderate-Risk Variants Among Breast Cancer Patients and Healthy Donors Enrolled in Multigene Panel Testing in a Population of Central Russia. | Int J Mol Sci | 2024 | 39684352 | PubTator, text mining | PubMed |
| Comprehensive Clinical Genetics, Molecular and Pathological Evaluation Efficiently Assist Diagnostics and Therapy Selection in Breast Cancer Patients with Hereditary Genetic Background. | Int J Mol Sci | 2024 | 39684258 | PubTator, text mining | PubMed |
A phase II study evaluating safety and efficacy of niraparib in patients with previously treated homologous recombination defective metastatic esophageal/gastroesophageal junction/proximal gastric adenocarcinoma. | Front Oncol | 2024 | 39640282 | PubTator, text mining | PubMed |
| Functional profiling of murine glioma models highlights targetable immune evasion phenotypes. | Acta Neuropathol | 2024 | 39592459 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/580/papers?page=10